➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Baxter
AstraZeneca
Colorcon
Harvard Business School

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Patent: 10,118,956

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,118,956
Title:Fusion partners for peptide production
Abstract: The present invention relates to the field of medicine, in particular, to the production of large amounts of a soluble recombinant polypeptide as part of a fusion protein comprising an N-terminal fusion partner linked to the polypeptide of interest.
Inventor(s): Retallack; Diane M. (Poway, CA), Chapman; Adam (San Diego, CA), Bruck; Torben R. (Lakeside, CA), Jin; Hongfan (San Diego, CA)
Assignee: PFENEX INC. (San Diego, CA)
Application Number:14/954,766
Patent Claims:see list of patent claims

Details for Patent 10,118,956

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Mylan Pharms Inc SEMGLEE insulin glargine INJECTABLE;INJECTION 210605 001 2020-06-11 ⤷  Free Forever Trial PFENEX INC. (San Diego, CA) 2034-12-01 RX search
Novo FIASP PENFILL insulin aspart SOLUTION;SUBCUTANEOUS 208751 003 2018-03-06 ⤷  Free Forever Trial PFENEX INC. (San Diego, CA) 2034-12-01 RX search
Novo FIASP FLEXTOUCH insulin aspart SOLUTION;SUBCUTANEOUS 208751 002 2018-03-06 ⤷  Free Forever Trial PFENEX INC. (San Diego, CA) 2034-12-01 RX search
Novo FIASP insulin aspart SOLUTION;INTRAVENOUS, SUBCUTANEOUS 208751 001 2018-03-06 ⤷  Free Forever Trial PFENEX INC. (San Diego, CA) 2034-12-01 RX search
Eli Lilly And Co BASAGLAR insulin glargine SOLUTION;SUBCUTANEOUS 205692 001 2016-06-17 ⤷  Free Forever Trial PFENEX INC. (San Diego, CA) 2034-12-01 RX search
Smith And Nephew REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ⤷  Free Forever Trial PFENEX INC. (San Diego, CA) 2034-12-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,118,956

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2016089782 ⤷  Free Forever Trial
United States of America 10981968 ⤷  Free Forever Trial
United States of America 2016159877 ⤷  Free Forever Trial
United States of America 2019135889 ⤷  Free Forever Trial
Taiwan 201629226 ⤷  Free Forever Trial
Taiwan I702289 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKesson
Johnson and Johnson
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.